Generation and Validation of a Clinical Prediction Rule for Sedative-Associated Delirium During Acute Respiratory Failure
急性呼吸衰竭期间镇静相关谵妄的临床预测规则的生成和验证
基本信息
- 批准号:10676716
- 负责人:
- 金额:$ 4.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute respiratory failureAddressAdultAffectAlzheimer&aposs DiseaseAmericanAttentionAwarenessCOVID-19COVID-19 pandemicCOVID-19 patientCalibrationCharacteristicsClinicalClinical ResearchCognitionCohort StudiesConvalescenceCritical CareCritical IllnessDataData SetDecision MakingDeliriumDevelopmentDiscriminationExposure toFunctional disorderFundingGenerationsHealth Care CostsImpaired cognitionIntensive Care UnitsKnowledgeLeadLength of StayLogistic RegressionsMechanical ventilationMentorsMulticenter StudiesNational Heart, Lung, and Blood InstituteNational Research Service AwardsOutcomePatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologyPredictive FactorProspective cohort studyResearch MethodologyResearch PersonnelRiskRisk FactorsSedation procedureSeveritiesSurvivorsSyndromeTechniquesTestingTrainingTraining ProgramsTraumatic Brain InjuryTreatment FactorValidationWorkadverse outcomebasebrain dysfunctioncareercognitive testingcohortconfusion assessment methoddisabilityeffective therapyexperiencefollow-uphigh riskimprovedimproved outcomeindexinginnovationmortalityoptimismpersonalized decisionpreclinical studyprospectivesedativeskillstooltranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
More than half of the >10 million patients who are mechanically ventilated for acute respiratory failure
throughout the world each year experience delirium, a brain dysfunction syndrome characterized by acute
disturbances in attention, awareness, and cognition. Delirium is a risk factor for numerous adverse outcomes,
including delayed liberation from mechanical ventilation, increased health care costs, increased mortality,
and—for those who survive—long-term disability and persistent cognitive impairment. Up to one third of
survivors of acute respiratory failure are affected by long-term cognitive impairment, the severity of which is
similar to that caused by traumatic brain injury or Alzheimer’s Disease. The pathophysiology of delirium during
acute respiratory failure remains poorly understood, and effective therapies have yet to be identified. Thus,
avoidance of risk factors is key to improving outcomes. One of the common risk factors for delirium during
acute respiratory failure is exposure to sedating medications, which are often necessary when managing
mechanically ventilated patients. When choosing whether and how to sedate a patient with acute respiratory
failure, a clinician would ideally use information about risk for sedative-associated delirium, the duration of
which predicts long-term cognitive impairment. The identification and quantification of risk for sedative-
associated delirium during acute respiratory failure would allow clinicians to personalize decision-making
regarding sedation in the intensive care unit (ICU), making efforts to avoid sedation (or avoid specific
sedatives) when managing those patients at high risk for sedative-associated delirium. Such an approach to
personalized sedation would lead to less delirium and to improved patient-centered outcomes. Thus, we plan
in this NRSA project to test the central hypothesis that risk for sedative-associated delirium during acute
respiratory failure can be quantified in a clinical prediction rule based on patient characteristics and treatment
factors. To test this hypothesis, we will accomplish two specific aims. First, we use existing data collected
during the multicenter, prospective BRAIN-ICU cohort study to derive a clinical prediction rule that uses readily
available patient characteristics and treatment factors to predict sedative-associated delirium among adults
with acute respiratory failure (Aim 1). Next, we will validate the sedative-associated delirium clinical prediction
rule both internally to correct estimates for optimism (Aim 2A) and externally, assessing calibration and
discrimination in two ongoing, NHLBI-funded prospective cohort studies (Aim 2B). During this project, the
applicant’s mentors and training program will provide him with expert training in clinical research methodology
and cognitive assessments and outcomes, and he will cultivate the skills necessary for a career as an
independent clinical researcher in the field of critical care.
项目总结/文摘
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Treatment of Delirium During Critical Illness.
- DOI:10.1146/annurev-med-042220-013015
- 发表时间:2022-01-27
- 期刊:
- 影响因子:10.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niall Prendergast其他文献
Niall Prendergast的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niall Prendergast', 18)}}的其他基金
Generation and Validation of a Clinical Prediction Rule for Sedative-Associated Delirium During Acute Respiratory Failure
急性呼吸衰竭期间镇静相关谵妄的临床预测规则的生成和验证
- 批准号:
10231537 - 财政年份:2021
- 资助金额:
$ 4.38万 - 项目类别:
相似海外基金
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
- 批准号:
10724042 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
- 批准号:
10633823 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
- 批准号:
10739060 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
- 批准号:
10731311 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
- 批准号:
10622756 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
- 批准号:
10732929 - 财政年份:2023
- 资助金额:
$ 4.38万 - 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
- 批准号:
10313769 - 财政年份:2022
- 资助金额:
$ 4.38万 - 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
- 批准号:
10413457 - 财政年份:2022
- 资助金额:
$ 4.38万 - 项目类别: